Comparison results
| Results: Differences General | ✘E23.2 | ✘E26 | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | 12% | ||||
| Register, to see more distinctive signs of diseases and studies | — | 26% | ||||
| warts on the legs | 79% | — | ||||
| adrenal hyperplasia | — | 25% | ||||
| quickly gets tired | 78% | — | ||||
| tumors of the adrenal glands | — | 23% | ||||
| no strength | 63% | — | ||||
| myasthenia | — | 18% | ||||
| diabetes insipidus | 62% | — | ||||
| hormonal disorders | — | 17% | ||||
| warts | 56% | — | ||||
| hypertension | — | 17% | ||||
| tremor | 55% | — | ||||
| aching pains in the heart | — | 17% | ||||
| wolfram syndrome | 45% | — | ||||
| muscle weakness | — | 17% | ||||
| nephrogenic diabetes insipidus | 37% | — | ||||
| aldosteroma | — | 16% | ||||
| little urine | 36% | — | ||||
| weakness after stress | — | 16% | ||||
| polyuria | 36% | — | ||||
| increased sodium | — | 16% | ||||
| volume of residual urine is reduced | 34% | — | ||||
| essential hypertension | — | 15% | ||||
| does not urinate | 31% | — | ||||
| oncology | — | 15% | ||||
| hydroureter | 30% | — | ||||
| adrenal cancer | — | 15% | ||||
| pituitary gland diseases | 30% | — | ||||
| excess aldosterone | — | 15% | ||||
| urine does not leave | 29% | — | ||||
| decreased potassium | — | 15% | ||||
| hypotonic dehydration | 28% | — | ||||
| addison 's crisis | — | 13% | ||||
| dehydration | 28% | — | ||||
| myocardial dystrophy | — | 13% | ||||
| hypopituitarism | 27% | — | ||||
| impaired arterial function | — | 13% | ||||
| pituitary tumors | 26% | — | ||||
| general weakness | — | 13% | ||||
| weakness no | 26% | — | ||||
| subacute condition | — | 12% | ||||
| urination with blood | 26% | — | ||||
| convulsions pain | — | 12% | ||||
| hypotension with weakness | 24% | — | ||||
| periodic paralysis | — | 12% | ||||
| weakness and palpitations | 24% | — | ||||
| attacks of weakness | — | 12% | ||||
| collapse | 24% | — | ||||
| discomfort in the heart | — | 12% | ||||
| cancer in the anamnesis | 22% | — | ||||
| benign neoplasms | — | 12% | ||||
| thirst | 22% | — | ||||
| renal hypertension | — | 11% | ||||
| rapid reaction | 20% | — | ||||
| primary-multiple tumors | — | 11% | ||||
| kidney failure | 20% | — | ||||
| headache aching | — | 11% | ||||
| decreased concentration of attention | 20% | — | ||||
| muscular dystrophy | — | 11% | ||||
| skin anesthesia | 19% | — | ||||
| symptomatic arterial hypertension | — | 11% | ||||
| hypotension | 19% | — | ||||
| decrease sodium | — | 11% | ||||
| overwork | 19% | — | ||||
| swelling of the extremities | — | 11% | ||||
| sepsis | 19% | — | ||||
| chronic kidney disease | — | 10% | ||||
| anesthesia | 18% | — | ||||
| speeded up urination | — | 10% | ||||
| acute condition | 18% | — | ||||
| constant tachycardia | — | 10% | ||||
| exhaustion | 18% | — | ||||
| adrenal insufficiency | — | 10% | ||||
| history of surgery | 21% | 7% | ||||
| constant heartbeat | — | 10% | ||||
| weakness in the heart | 23% | 10% | ||||
| tachycardia attacks | — | 10% | ||||
| tachycardia | 19% | 8% | ||||
| headache with weakness | — | 10% | ||||
| oncology in the anamnesis | 20% | 9% | ||||
| urination disorder | — | 10% | ||||
| palpitations | 18% | 8% | ||||
| visual impairment | — | 9% | ||||
| angioplasty | 16% | 8% | ||||
| vascular tumor | — | 9% | ||||
| impaired kidney function | 18% | 14% | ||||
| blurred vision | — | 9% | ||||
| not enough time | — | 9% | ||||
| nephropathy | — | 9% | ||||
| paralysis | — | 9% | ||||
| pain in the heart | — | 9% | ||||
| muscle hypertonus | — | 9% | ||||
| pain throughout the body | — | 9% | ||||
| changes in the blood | — | 8% | ||||
| aching | — | 8% | ||||
| spasm | — | 8% | ||||
| stress | — | 8% | ||||
| weakness after illness | — | 8% | ||||
| headaches | — | 8% | ||||
| роды и вскармливание | — | 8% | ||||
| cancer | — | 8% | ||||
| swelling | — | 8% | ||||
| onset of illness | — | 8% | ||||
| consequences of taking medications | — | 7% | ||||
Instructions
Video
|